Cita APA

Hildebrandt, M. A., Yang, H., Hung, M., Izzo, J. G., Huang, M., Lin, J., . . . Wu, X. (2009). Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy. American Society of Clinical Oncology.

Chicago Style Citation

Hildebrandt, Michelle A.T., Hushan Yang, Mien-Chie Hung, Julie G. Izzo, Maosheng Huang, Jie Lin, Jaffer A. Ajani, i Xifeng Wu. Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy. American Society of Clinical Oncology, 2009.

Cita MLA

Hildebrandt, Michelle A.T., et al. Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy. American Society of Clinical Oncology, 2009.